Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and Glomerulosclerosis, Focal Segmental

resveratrol has been researched along with Glomerulosclerosis, Focal Segmental in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, L; Liu, G; Liu, H; Peng, X; Peng, Y; Shi, Y; Wang, Q1
Huang, CY; Li, J; Liang, D; Liao, SC; Peng, X; Su, H; Ting, WJ1

Other Studies

2 other study(ies) available for resveratrol and Glomerulosclerosis, Focal Segmental

ArticleYear
Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway.
    Pharmacology, 2017, Volume: 100, Issue:5-6

    Topics: Animals; Anti-Inflammatory Agents; Doxorubicin; Fibrosis; Glomerulosclerosis, Focal Segmental; Kidney; Male; Mice; Mice, Inbred BALB C; Phosphotransferases (Alcohol Group Acceptor); Receptor, Anaphylatoxin C5a; Receptors, G-Protein-Coupled; Resveratrol; Signal Transduction; Stilbenes

2017
Ramipril and resveratrol co-treatment attenuates RhoA/ROCK pathway-regulated early-stage diabetic nephropathy-associated glomerulosclerosis in streptozotocin-induced diabetic rats.
    Environmental toxicology, 2019, Volume: 34, Issue:7

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Kidney; Male; Ramipril; Rats; Rats, Sprague-Dawley; Resveratrol; rho-Associated Kinases; rhoA GTP-Binding Protein; Severity of Illness Index; Signal Transduction; Streptozocin

2019